Conference Description:

The inaugural Operationalize: Expanded Access Programs Summit West | Improving Global Access to Life Changing Therapeutics.

Following the successful Boston and London meetings, the Operationalize Expanded Access Programs Summit West is uniting stakeholders executing Early Access, Expanded Access and Post-Trial Access Programs to share expertise in successfully bridging the gap between innovative clinical research and patients in need.

This Summit is the only West Coast forum connecting Expanded Access teams with industry peers to share case studies in overcoming operational and regulatory challenges to streamline access to life-changing therapies!

Join 60+ experts, from Eli Lilly, Gilead, Ultragenyx, Daiichi Sankyo and more for three jam-packed days in San Francisco this July. Get exclusive insights, real-world case studies and cutting-edge strategies to supercharge your Expanded Access Programs.


URL:
Tickets: https://go.evvnt.com/3028978-1?pid=154
Time: 9:00 AM - 5:00 PM

Prices:
Industry Pricing - On the Door Price - Conference + Workshop Day: USD 4197.00,
Industry Pricing - On the Door Price - Conference Only: USD 2999.00,
Academic Pricing - On the Door Price - Conference + Workshop Day: USD 3997.00,
Academic Pricing - On the Door Price - Conference Only: USD 2599.00,
Solution and Service Provider Pricing - On the Door Price - Conference + Workshop Day: USD 4697.00,
Solution and Service Provider Pricing - On the Door Price - Conference Only: USD 3699.00

Speakers: Anita Cruz Manager, IIT and Expanded Access Programs, Global Medical Affairs BeOne Medicines, Annie Drelles Senior Director and Head, Office of Medical Access, Global Oncology Medical Affairs Daiichi Sankyo, Becket Feierbach Senior Director, Medical Affairs Gilead Sciences, Ben Rotz Associate Vice President - Global Medical Policy, Strategy, and Operations Eli Lilly and Co., Brent Kreider President Biomed Valley Discoveries, Cara Hunt Senior Patient Advocacy Operations Specialist Cytokinetics, Catherynne Cruz-Scheckner Executive Director, Clinical Supplies Ionis Pharmaceuticals, Cybele Gouverneur Director, Global Patient Advocacy BridgeBio, Dawn Sullivan Expanded Access Advisor Independent Expert, Debra Litwak Senior Director, Global Medical Affairs - Investigator Initiated Trials and Expanded Access Programs BeOne Medicines, Dennis Akkaya Chief Commercial Officer myTomorrows, Harpreet Ram President GARDaccess, John Massarelli Pre-Approval Access Specialist myTomorrows, Kirsten Hoyer Associate Director Ascendis Pharma, Rafael Escandon Pediatric Gene Therapy Medical Ethics Working Group (PGTME) NYU Grossman School of Medicine, Richard Klein Director, Expanded Access Programs and Policy GE2P2 Global Foundation, Stephanie Ferket Director, Expanded Access Strategy and Customer Success myTomorrows, Stephen Smith Senior Director, Program Management Corcept Therapeutics, Vanessa Mora Senior Case Manager Ultragenyx Pharmaceuticals